Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

MEDRX vs. SHSSX: which is better?

Bottom line

MEDRX vs SHSSX: the short answer

MEDRX (Kinetics Medical Fund) and SHSSX (Blackrock Health Sciences Opportunities Portfolio) are both mutual funds.

Updated Nov 19, 2026

MEDRX vs SHSSX side by side

MEDRXSHSSX
TypeMutual fundMutual fund
Fund familyKinetics MutualBlackRock
CategoryHealth Care SectorHealth Care Sector
Expense ratio—0.86%
Annual cost per $10k—$86
10-yr cost on $10k (prospectus)—$1,061
Max front load—0%
12b-1 fee—0%
1-yr return—+16.3%
5-yr return (annualized)—+5.9%
10-yr return (annualized)—+9.8%
Best quarter——
Worst quarter——
Net assets (fund)—$5.9B
Number of holdings—155
Portfolio turnover—49%
Returns as of—Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

MEDRX and SHSSX share none of their top holdings.

MEDRX top 10

    SHSSX top 10

    1. Eli Lilly & Company — 12.29%
    2. Johnson & Johnson — 8.77%
    3. Unitedhealth Group Inc — 6.10%
    4. Merck & Company Inc — 4.94%
    5. Gilead Sciences Inc — 4.19%
    6. Abbvie Inc — 3.94%
    7. Amgen Inc — 3.37%
    8. Thermo Fisher Scientific Inc — 3.02%
    9. Vertex Pharmaceuticals Inc — 2.74%
    10. Pfizer Inc — 2.61%

    FAQ

    What is the difference between MEDRX and SHSSX?
    MEDRX (Kinetics Medical Fund) and SHSSX (Blackrock Health Sciences Opportunities Portfolio) are both mutual funds.
    Should I own both MEDRX and SHSSX?
    Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

    Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.